Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA.
Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Science. 2020 Mar 27;367(6485):1468-1473. doi: 10.1126/science.aay0939. Epub 2020 Feb 6.
Circulating tumor cells (CTCs) are shed into the bloodstream from primary tumors, but only a small subset of these cells generates metastases. We conducted an in vivo genome-wide CRISPR activation screen in CTCs from breast cancer patients to identify genes that promote distant metastasis in mice. Genes coding for ribosomal proteins and regulators of translation were enriched in this screen. Overexpression of , which encodes a component of the large ribosomal subunit, increased metastatic growth in multiple organs and selectively enhanced translation of other ribosomal proteins and cell cycle regulators. RNA sequencing of freshly isolated CTCs from breast cancer patients revealed a subset with strong ribosome and protein synthesis signatures; these CTCs expressed proliferation and epithelial markers and correlated with poor clinical outcome. Therapies targeting this aggressive subset of CTCs may merit exploration as potential suppressors of metastatic progression.
循环肿瘤细胞 (CTCs) 从原发性肿瘤脱落到血液中,但只有一小部分 CTC 会形成转移。我们在乳腺癌患者的 CTC 中进行了一项全基因组 CRISPR 激活筛选,以鉴定促进小鼠远处转移的基因。该筛选中富集了编码核糖体蛋白和翻译调节剂的基因。编码核糖体大亚基成分的 过表达增加了多个器官中的转移生长,并选择性地增强了其他核糖体蛋白和细胞周期调节剂的翻译。对从乳腺癌患者新鲜分离的 CTC 进行的 RNA 测序显示,具有强烈核糖体和蛋白质合成特征的 CTC 亚群;这些 CTC 表达增殖和上皮标志物,并与不良临床结局相关。针对这种侵袭性 CTC 亚群的治疗方法可能值得探索,作为抑制转移进展的潜在手段。